I consider the identification of miR-214 as a pro-metastatic miRNAs in melanoma and breast cancer as a milestone in my career followed by the demonstration that miR-214 inhibition is able to reduce tumor dissemination. This discovery has led to the patenting of a molecule with potential application in the clinics.